Drug Shortage Report for SANDOZ TRANDOLAPRIL

Last updated on 2020-11-28 History
Report ID 127782
Drug Identification Number 02325764
Brand name SANDOZ TRANDOLAPRIL
Common or Proper name SANDOZ TRANSOLAPRIL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TRANDOLAPRIL
Strength(s) 4MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100HGC BO CA
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-10-30
Estimated end date
Actual end date 2020-11-27
Shortage status Resolved
Updated date 2020-11-28
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-11-28 English Compare
v4 2020-11-26 French Compare
v3 2020-11-26 English Compare
v2 2020-11-04 French Compare
v1 2020-11-04 English Compare